arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Nektar Therapeutics

NKTR Health Care Biotechnology: Pharmaceutical Preparations
$57.32
▼ -3.4% Today
as of Jun 7, 07:22 ET
Last 30 days -31.61% Apr 28 → Jun 05
$54.95 $63.53 $72.10 $80.68 $89.26 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$59.24
High
$59.98
Low
$56.81
Volume
$1M
Avg Vol
$1M
Mkt Cap
$2.2B
P/E (TTM)
Beta
52w High
$109.00
52w Low
$7.99
Div Yield
Shares Out
$20M

Overview

52-week range
$7.99
$109
49% of range
Avg surprise (last 2)
-13.4%
Avg reaction (last 2)
-0.2%
50% positive
Latest IV / EM
74%
EM ±10.2% · $55 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.76$-2.86$-1.97$-1.08$-0.18 Actual $-0.27Actual $-0.24Actual $-0.19Actual $-3.76Actual $-2.66Actual $-0.22Est $-0.18Actual $-2.95Actual $-1.87Actual $-1.82Est $-1.74 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-52M$-49M$-45M$-41M$-37M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.82 $-1.74 -4.6% -727.3% -2.0% earnings
Tue Sep 30, 2025Sep 2025 $-1.87 financials
Mon Jun 30, 2025Jun 2025 $-2.95 financials
Thu May 8, 2025Mar/2025 $-0.22 $-0.18 -22.2% +1.6% earnings
Mon Sep 30, 2024Sep 2024 $-2.66 financials
Sun Jun 30, 2024Jun 2024 $-3.76 financials
Sun Mar 31, 2024Mar 2024 $-0.19 financials
Sat Sep 30, 2023Sep 2023 $-0.24 financials
Fri Jun 30, 2023Jun 2023 $-0.27 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$0$0$0$4M$10M
Gross profit
Operating income$-39M$-32M$-36M$-45M$-34M$-50M
Net income$-45M$-36M$-42M$-51M$-37M$-52M
EPS (diluted)$-1.82$-1.87$-2.95$-3.62$-2.66$-3.76

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$150M$15M$41M$43M$39M$44M$30M$28M
Inventory$0$14M
Total current assets$589M$266M$281M$187M$230M$261M$286M$295M
Total assets$763M$280M$301M$208M$256M$304M$308M$343M
Long-term debt
Total liabilities$187M$191M$216M$232M$243M$243M$259M$264M
Total equity$576M$90M$85M$-24M$14M$61M$49M$80M

Implied volatility — last 90 days

69%71%74%76%79% Jun 07 — IV 74% · EM ±10.2%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.